Clinical trial
A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy
NCT00470457 · University of Zurich, Other · Completed
Key facts
| NCT number | NCT00470457 |
|---|---|
| Title | A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy |
| Official title | A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy in Grass and/or Tree Pollen Allergic Subjects by Intralymphatic Allergen Administration |
| Lead sponsor | University of Zurich, Other |
| Collaborators | AlleCure Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhinoconjunctivitis Due to Grass Pollen Allergy |
| Intervention type | Biological |
| Interventions | Allergen specific immunotherapy |
| Enrollment | 156 |
| Start date | Jun 1, 2001 |
| Completion | Mar 1, 2005 |
| First posted | May 7, 2007 |
| Last update posted | Dec 3, 2015 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: